As Medtronic begins rolling out a recently FDA-cleared diabetes management system combining its MiniMed 780G insulin pump and Abbott’s Instinct glucose sensor, the medtech giant has launched a new ...

Medtronic is a solid choice for dividend investors, but Intuitive Surgical is a better option for growth-oriented investors. Intuitive Surgical will continue dominating its niche even as Medtronic ...

Medtronic has launched the MiniMed 780G system in the U.S., integrated with Abbott’s Instinct sensor technology. Medtronic’s integration with Abbott was just approved by FDA in September, broadening ...

Medtronic's cardiovascular sales rise 10.8% to $3.44 bln CEO emphasizes on cardiology and neuroscience M&A CFO confirms diabetes business to go public in 2026 Nov 18 (Reuters) - Medtronic (MDT.N), ...

Medtronic MDT-1.18%decrease; red down pointing triangle raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and ...

Medtronic Fails at Attempt to Escape Whistleblower Suit Under New Standard, Judge Rules "In sum, although the court previously rejected (and thus did not consider) the application of a but-for ...

Medtronic saw $9 billion in global revenue, a 6.6% year over year increase, in the second quarter of fiscal year 2026, according to financial results posted Nov. 18. Five things to know: 1.

From left to right: Katie Adams, assistant editor at MedCity News; and Jennifer Thompson, vice president of U.S. aortic sales at Medtronic The process of commercializing a new medical device is ...

Medtronic's shares have sharply rallied over the last six months. The medtech giant's growth catalysts include a best-in-class product (Affera) in a fast-growing $11 billion space and a massive ...

Medtronic PLC’s stock fell 7.3% as the worst performer in the S&P 500 on Tuesday after the medical-products company’s earnings fell slightly short of Wall Street’s revenue target despite a ...